Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension.
Marshall, A J
Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension. [electronic resource] - British journal of clinical pharmacology Sep 1980 - 217-21 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0306-5251
10.1111/j.1365-2125.1980.tb01747.x doi
Bendroflumethiazide--therapeutic use
Blood Pressure--drug effects
Drug Therapy, Combination
Female
Heart Rate--drug effects
Humans
Hypertension--drug therapy
Indoles--therapeutic use
Indoramin--adverse effects
Male
Oxprenolol--therapeutic use
Sleep Wake Disorders--chemically induced
Evaluation of indoramin added to oxprenolol and bendrofluazide as a third agent in severe hypertension. [electronic resource] - British journal of clinical pharmacology Sep 1980 - 217-21 p. digital
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
0306-5251
10.1111/j.1365-2125.1980.tb01747.x doi
Bendroflumethiazide--therapeutic use
Blood Pressure--drug effects
Drug Therapy, Combination
Female
Heart Rate--drug effects
Humans
Hypertension--drug therapy
Indoles--therapeutic use
Indoramin--adverse effects
Male
Oxprenolol--therapeutic use
Sleep Wake Disorders--chemically induced